Welcome to our dedicated page for Magnera SEC filings (Ticker: MAGN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Magnera Corporation’s (NYSE: MAGN) SEC filings, offering a structured view of the company’s regulatory disclosures. Magnera is a Pennsylvania‑incorporated specialty materials company listed on the New York Stock Exchange under the symbol MAGN, serving more than 1,000 customers worldwide with components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products for the food and beverage industry.
Through its filings with the U.S. Securities and Exchange Commission, Magnera reports information about its financial condition, results of operations, governance, and executive compensation. Annual reports on Form 10‑K and quarterly reports on Form 10‑Q detail segment performance for the Americas and Rest of World, cash flow from operating activities, capital expenditures, property, plant and equipment, goodwill and intangible assets, and non‑GAAP metrics such as adjusted EBITDA and free cash flow, along with reconciliations.
Current reports on Form 8‑K disclose material events, including quarterly and annual earnings releases, guidance updates, officer departures, and information about the timing of the annual meeting of shareholders. These filings also confirm Magnera’s exchange listing, state of incorporation, and other key registrant details. Definitive proxy statements on Schedule 14A describe board composition, committee structure, corporate governance practices, and the design of executive compensation programs, including pay‑for‑performance elements and stock ownership guidelines.
On Stock Titan, AI‑powered tools summarize lengthy filings so readers can quickly identify major topics such as changes in leverage, cash flow trends, Project CORE transformation activities, and items related to director elections or say‑on‑pay proposals. Users can review real‑time updates as new documents are posted to EDGAR, including Forms 10‑K, 10‑Q, 8‑K, and proxy statements, and use the summaries to focus on sections most relevant to their analysis of MAGN.
RICKERTSEN CARL J reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Carl J. Rickertsen received a grant of 12,998 restricted stock units (RSUs), representing the right to receive an equal number of shares of common stock. The RSUs were awarded at a price of
According to the terms, this grant vests in full and all restrictions lapse one year from the grant date on
Magnera Corp reported that director Salmon Tom received a grant of 12,998 Restricted Stock Units on the company’s common stock, par value $.01 per share. The grant is classified as a derivative award acquisition with no cash exercise price.
According to the disclosure, these 2026 director RSUs vest in full and all restrictions lapse one year from the grant date. The filing shows 12,998 RSUs outstanding following the transaction, and notes that the units have no value until all restrictions lapse on the final vesting date.
Magnera Corp director Samantha J. Marnick received a grant of 12,998 Restricted Stock Units (RSUs) on the reported grant date. These RSUs were acquired at a price of $0.00 per unit as a director equity award and are held as direct ownership.
According to the footnotes, this 2026 director grant vests in full and all restrictions lapse one year from the grant date. The RSUs have no value until all restrictions lapse on the final vesting date, meaning their benefit depends on future vesting and the company’s share value at that time.
Hall Mary Dean reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Mary Dean Hall received a grant of 12,998 Restricted Stock Units. These RSUs were awarded at no cash cost and will vest in full, with all restrictions lapsing, one year from the grant date. According to the disclosure, the RSUs have no value until all restrictions lapse on the final vesting date.
Curless Michael S reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Michael S. Curless received a grant of 12,998 Restricted Stock Units (RSUs) on the reported date. These RSUs were awarded at a price of $0.00 per unit, reflecting an equity-based compensation award rather than an open-market purchase.
Following this grant, Curless beneficially owns 12,998 RSUs directly. According to the footnotes, this 2026 director grant vests in full and all restrictions lapse one year from the grant date, and the RSUs have no value until all restrictions lapse on the final vesting date.
Fogarty Kevin Michael reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Kevin Michael Fogarty was granted 12,998 restricted stock units (RSUs). The RSUs were awarded on the grant date with no cash price per unit. According to the award terms, this 2026 director grant vests in full and all restrictions lapse one year from the grant date.
Fahnemann Thomas reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Thomas Fahnemann received a grant of 12,998 Restricted Stock Units (RSUs) on March 9, 2026. The RSUs were awarded at a price of $0.00 per unit as a 2026 director grant.
According to the footnotes, these RSUs have no value until all restrictions lapse on the final vesting date. The 2026 director grant vests in full, and all restrictions lapse one year from the grant date, after which the units may deliver economic value to the director.
Brown Bruce reported acquisition or exercise transactions in this Form 4 filing.
Magnera Corp director Bruce Brown received a grant of 12,998 restricted stock units (RSUs). The RSUs were awarded on March 9, 2026 at a price of $0.00 per unit, reflecting a non-cash equity award rather than an open-market purchase.
According to the terms, this 2026 director grant vests in full and all restrictions lapse one year from the grant date. The footnotes state that these RSUs have no value until all restrictions lapse on the final vesting date, meaning their economic benefit depends on future vesting.
Magnera Corp executive Jill L. Urey reported equity award activity involving restricted stock units and common shares. On February 28, 2026, she exercised 1,571 restricted stock units, converting them into the same number of common shares at a reference price of $12.95 per share. A portion of these shares, 521 common shares, was withheld to cover tax obligations, leaving her with 5,134 common shares held directly after the transactions.
Magnera Corp executive Jill L. Urey, EVP, General Counsel and Corporate Secretary, reported routine equity compensation activity. On February 24, 2026, she exercised 205 restricted stock units, converting them into an equal number of common shares at
To cover tax obligations related to this vesting, 68 common shares were disposed of through a tax-withholding transaction, rather than an open-market sale. After these transactions, Urey directly owned 4,084 shares of Magnera common stock. The RSUs were part of a 2023 long-term incentive grant that vested in three annual installments.